Identification of sulfamethoxazole's residues in sulfamethoxazole induced kidney stones by mass spectrometry
- PMID: 37775272
- DOI: 10.1515/cclm-2023-0984
Identification of sulfamethoxazole's residues in sulfamethoxazole induced kidney stones by mass spectrometry
Keywords: FT-IR; LC/MS-MS; drug-induced nephrolithiasis; kidney stones; mass spectrometry; sulfamethoxazole.
References
-
- Marangella, M. Medical management of urinary calculi: up to date 2016. Urologia 2016;83:110–23. https://doi.org/10.5301/uro.5000180 . - DOI
-
- Tiselius, HG. Epidemiology and medical management of stone disease. BJU Int 2003;91:758–67. https://doi.org/10.1046/j.1464-410x.2003.04208.x . - DOI
-
- Daudon, M, Frochot, V, Bazin, D, Jungers, P. Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment. Drugs 2018;78:163–201. https://doi.org/10.1007/s40265-017-0853-7 . - DOI
-
- García-Galán, MJ, Díaz-Cruz, MS, Barceló, D. Identification and determination of metabolites and degradation products of sulfonamide antibiotics. Trends Anal Chem 2008;27:1008–22. https://doi.org/10.1016/j.trac.2008.10.001 . - DOI
-
- Roedel, MM, Nakada, SY, Penniston, KL. Sulfamethoxazole-induced sulfamethoxazole urolithiasis: a case report. BMC Urol 2021;21:133. https://doi.org/10.1186/s12894-021-00894-5 . - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources